Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Kyung Nam Pharm Co., Ltd. (053950)
Market Closed
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
1,671.
00
-6
-0.3578%
₩
32.9B
Market Cap
-
P/E Ratio
160%
Div Yield
29,895
Volume
-
Eps
₩
1,677
Previous Close
Watching
Watch
Add Transaction
Day Range
1,652
1,700
Year Range
1,415
5,580
Want to track
053950
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Splits
Statistics
Historical Data
Kyung Nam Pharm Co., Ltd. (053950) Statistics
Valuation metrics
Market Cap
32.9B
Enterprise value
62.53B
Trailing P/E (ttm)
-3.66
Forward P/E
-
PEG ratio
0.07
Price/Sales (ttm)
0.59
Price/Book (mrq)
0.26
Enterprise Value/Revenue
1.12
Enterprise Value/EBITDA
-57.23
Overview
Shares outstanding
15.63M
Float
-
Shares short
-
% Held by insiders
-
% Held by institutions
-
Average volume (10 days)
169.16K
Average volume (90 days)
152.89K
Price summary
52-Week low
1,415
52-Week high
5,580
Beta
-
50-Day moving average
3,492.18
200-Day moving average
3,394.27
Dividends and splits
Forward annual dividend rate
160
Forward annual dividend yield
0.076%
Trailing annual dividend rate
40
Trailing annual dividend yield
0.019%
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
5 Jan 2005
Ex-Dividend Date
29 Dec 2004
Last split factor
0.2:1
Last split Date
14 Apr 2026
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.27%
Operating margin
-0.14%
Operational effectiveness
Return on assets
-0.06%
Return on equity
-0.08%
Income Statement
Revenue (ttm)
55.94B
Revenue per share (ttm)
3,571.57
Quarterly revenue growth (yoy)
0.1%
Gross profit (ttm)
15.15B
EBITDA
2.48B
Net income to common (ttm)
-9.01B
Diluted EPS (ttm)
-575
Quarterly earnings growth (yoy)
0.23%
Balance Sheet
Total cash (mrq)
4.33M
Total cash per share (mrq)
0.28
Total debt (mrq)
36.24B
Total Debt/Equity (mrq)
0.29
Current ratio (mrq)
1.75%
Book value per share (mrq)
8,007.68
Cash Flow
Cash flow statement
-10.8B
Levered free cash flow (LFCF)
-9.01B